Inovio Pharmaceuticals (INO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company’s earnings picture, â¦ [+5003 chars]Source
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.